Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
On 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health and Social Care, signed a Termination and Settlement Agreement and an amendment to resolve disputes over their updated COVID-19 vaccine supply contract from July 1,
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...
A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...
Seasonal influenza epidemics impose substantial burdens on healthcare systems and cause >5 million hospitalizations of adults each year.
The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.
Refusal of COVID-19 and influenza vaccinations was higher among White patients at an allergy/immunology clinic with a diverse ...
Animal health companies are developing vaccines that improve the breadth and effectiveness of protection against avian ...
Influenza and 2023 to 2024 COVID-19 vaccination coverage is 80.7% and 15.3%, respectively, among health care personnel at acute care hospitals and is lower among health care personnel at nursing homes ...
The first research programs attempting to develop an inactivated influenza vaccine, outside of the USSR, were conducted in England and in the USA at about the same time. However, it was at the ...
Two strains of influenza A, H1N1 and H3N2, affect people. Scientists always include these strains in the annual flu vaccine. Influenza A viruses are the ones that have been responsible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback